$5.07
-0.54-9.63%
Pre-Market: Jul 3, 3:58 PM EDT
15 minutes delayed
ESSA Pharma
EPIXNASDAQ
ESSA Pharma (NASDAQ:EPIX) Stock, Analyst Ratings, Price Targets, Forecasts
ESSA Pharma Inc has a consensus price target of $18 based on the ratings of 3 analysts. The high is $20 issued by Piper Sandler on May 12, 2022. The low is $17 issued by Oppenheimer on May 16, 2024. The 3 most-recent analyst ratings were released by Oppenheimer on May 16, 2024, December 13, 2023, and August 9, 2023, respectively. With an average price target of $17 between Oppenheimer, there's an implied 235.31% upside for ESSA Pharma Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
Oppenheimer
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for ESSA Pharma
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/16/2024 | Buy Now | 235.31% | Oppenheimer | Leland Gershell | $17 → $17 | Maintains | Outperform | Get Alert |
| 12/13/2023 | Buy Now | 235.31% | Oppenheimer | Mark Breidenbach | → $17 | Reiterates | Outperform → Outperform | Get Alert |
| 08/09/2023 | Buy Now | 235.31% | Oppenheimer | Mark Breidenbach | → $17 | Reiterates | Outperform → Outperform | Get Alert |
| 06/26/2023 | Buy Now | 235.31% | Oppenheimer | Mark Breidenbach | → $17 | Assumes | → Outperform | Get Alert |
| 05/12/2022 | Buy Now | 294.48% | Piper Sandler | Joseph Catanzaro | $50 → $20 | Maintains | Overweight | Get Alert |
| 08/17/2021 | Buy Now | 333.93% | Oppenheimer | Mark Breidenbach | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for ESSA Pharma (EPIX) stock?
The latest price target for ESSA Pharma (NASDAQ:EPIX) was reported by Oppenheimer on May 16, 2024. The analyst firm set a price target for $17.00 expecting EPIX to rise to within 12 months (a possible 235.31% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ESSA Pharma (EPIX)?
The latest analyst rating for ESSA Pharma (NASDAQ:EPIX) was provided by Oppenheimer, and ESSA Pharma maintained their outperform rating.
When was the last upgrade for ESSA Pharma (EPIX)?
There is no last upgrade for ESSA Pharma
When was the last downgrade for ESSA Pharma (EPIX)?
There is no last downgrade for ESSA Pharma.
When is the next analyst rating going to be posted or updated for ESSA Pharma (EPIX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ESSA Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ESSA Pharma was filed on May 16, 2024 so you should expect the next rating to be made available sometime around May 16, 2025.
Is the Analyst Rating ESSA Pharma (EPIX) correct?
While ratings are subjective and will change, the latest ESSA Pharma (EPIX) rating was a maintained with a price target of $17.00 to $17.00. The current price ESSA Pharma (EPIX) is trading at is $5.07, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.